Tatjana M. Trost

Premature Senescence Is a Primary Fail-safe Mechanism of ERBB2-Driven Tumorigenesis in Breast Carcinoma Cells

Tatjana M. Trost, Ekkehart Lausch, Stephan Fees et al. · Cancer Research · 2005 · 98 citations · Full text

ERBB2-Mediated Transcriptional Up-regulation of the α5β1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions

Christian Spangenberg, Ekkehart Lausch, Tatjana M. Trost et al. · Cancer Research · 2006 · 67 citations · Full text

Cancer Biology, Tumor Biology, Signaling Pathway +18

Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.

Ilka B. Schiffer, Susanne Gebhard, Carolin K. Heimerdinger et al. · PubMed · 2003 · 42 citations

Breast Oncology, Immunology, Recurrent Tumor Growth +16

4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models

Kurt Eger, Matthias Hermes, Kathrin Uhlemann et al. · Biochemical and Biophysical Research Communications · 2004 · 22 citations

Systems Biology, Conditional Mouse Models, Medicine +6

Dephosphorylation of p‐ERK1/2 in relation to tumor remission after HER‐2 and Raf1 blocking therapy in a conditional mouse tumor model

Carolin K. Hausherr, Ilka B. Schiffer, Susanne Gebhard et al. · Molecular Carcinogenesis · 2006 · 11 citations